NCT00287417View on ClinicalTrials.gov

Early Ultrasound and Maternal Biochemical Markers to Evaluate the Risk of Down Syndrome During the First Trimester

CompletedOBSERVATIONAL
Enrollment

20,000

Participants

Timeline

Start Date

July 31, 2003

Study Completion Date

February 28, 2011

Conditions
Down Syndrome
Interventions
DEVICE

echography

OTHER

blood sample

Trial Locations (7)

67000

Clinique ADASSA, Strasbourg

67098

Département de Gynécologie-Obstétrique, Hôpital de Hautepierre, Hôpitaux Universitaires de Strasbourg, Strasbourg

67303

Service de Gynécologie-Obstétrique, SIHCUS, CMCO, Strasbourg

68024

Centre Mère et Enfant LE PARC, Service de Gynécologie Obstétrique, Colmar

68051

Centre Hospitalier du Hasenrain, Mulhouse

68500

Centre de Périnatalité, Hôpital Civil, Guebwiller

90000

Centre Hospitalier, Belfort

All Listed Sponsors
lead

University Hospital, Strasbourg, France

OTHER

NCT00287417 - Early Ultrasound and Maternal Biochemical Markers to Evaluate the Risk of Down Syndrome During the First Trimester | Biotech Hunter | Biotech Hunter